Skip to main content
TTrialFinderData
TrialFinderData is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Movement Disorders Clinical Trials

Reviewed by TrialFinderData Editorial Team · Updated

3 recruiting trials for Movement Disorders. Eligibility criteria explained in plain English.

TrialFinderData lists 3 Movement Disorders clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.

Research is led by Radboud University Medical Center (1), Boston Children's Hospital (1), Target ALS Foundation, Inc. (1), among the most active sponsors registered for these trials.

The most frequently studied intervention is Step count increase with the use of a motivational smartphone application (behavioral, 1 trial).

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
3
Total Trials
3
Recruiting Now
0
Phase 3 Trials
3
Sponsors

Track Movement Disorders trials

Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT04848077

STEPWISE Parkinson: A Smartphone Based Exercise Solution for Patients With Parkinson's Disease

The aim of this study is to investigate whether a smartphone app can increase physical activity in patients with Parkinson's Disease in daily life for a long period of time (12...

Sponsor: Radboud University Medical CenterEnrolling: 4521 location
RECRUITINGNCT06585618

A Multicenter Pediatric Deep Brain Stimulation Registry

There is limited data on outcomes for children who have undergone deep brain stimulation (DBS) for movement disorders, and individual centers performing this surgery often lack...

Sponsor: Boston Children's HospitalEnrolling: 1001 location
RECRUITINGNCT05137665

Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At Home Measures

The goal of the study is to generate a biorepository of longitudinal biofluids-blood (plasma and serum), cerebral spinal fluid (CSF) and urine linked to genetics and longitudinal...

Sponsor: Target ALS Foundation, Inc.Enrolling: 100012 locations

Frequently Asked Questions

There are currently 3 clinical trials for Movement Disorders, with 3 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for Movement Disorders, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Movement Disorders, representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.